HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-1.63%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.83B
AUM Growth
+$2.83B
(-7.7%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.59%
Top 10 Holdings %
Top 10 Hldgs %
54.57%
Holding
55
New
19
Increased
10
Reduced
13
Closed
12
Top Buys
| 1 |
Dentsply Sirona
XRAY
|
$145M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$103M |
| 3 |
Zimmer Biomet
ZBH
|
$87.2M |
| 4 |
Agilent Technologies
A
|
$70.5M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$68.3M |
Top Sells
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$202M |
| 2 |
Medtronic
MDT
|
$147M |
| 3 |
Incyte
INCY
|
$102M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$93.7M |
| 5 |
CELG
Celgene Corp
CELG
|
$93.1M |
Sector Composition
| 1 | Healthcare | 93.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zoetis
ZTS
$69.3B
| – | – | -645,100 | Closed | -$46.5M |
|
|
CLVS
52
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | -973,840 | Closed | -$66.2M |
|
|
FPRX
53
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – | -101,000 | Closed | -$2.21M |
|
|
MNK
54
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -284,400 | Closed | -$6.42M |
|
|
BIVV
55
DELISTED
Bioverativ Inc. Common Stock
BIVV
| – | – | -3,750,000 | Closed | -$202M |
|